Nektar Therapeutics(NASDAQ : NKTR)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.23%||164.48||0.7%||$988.09m|
|MRK||Merck & Co., Inc.||0.81%||73.64||0.7%||$914.30m|
|LLY||Eli Lilly & Co.||-0.26%||231.58||1.1%||$588.95m|
|BMY||Bristol-Myers Squibb Co.||-0.61%||60.26||1.0%||$575.61m|
|CRVS||Corvus Pharmaceuticals, Inc.||-3.27%||6.80||0.7%||$140.27m|
|RPRX||Royalty Pharma Plc||-0.08%||37.10||0.1%||$121.13m|
|NVO||Novo Nordisk A/S||-1.36%||100.71||0.1%||$101.76m|
Nektar Therapeutics is a research-based biopharmaceutical company that focuses on discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and auto-immune disease. The company was founded in 1990 and is headquartered in San Francisco, CA.